Prevalence of Physical Frailty: Results from the DO-HEALTH Study - 21/11/24

Doi : 10.14283/jfa.2021.18 
Michael Gagesch 1, 2, , P.O. Chocano-Bedoya 2, 3, L.A. Abderhalden 1, 2, G. Freystaetter 1, 2, A. Sadlon 1, 2, J.A. Kanis 4, 5, R.W. Kressig 6, S. Guyonnet 7, J.A.P. DaSilva 8, D. Felsenberg 9, R. Rizzoli 10, M. Blauth 11, E.J. Orav 12, A. Egli 2, H.A. Bischoff-Ferrari 1, 2, 13
1 Department of Geriatrics, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland 
2 Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland 
3 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland 
4 Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia 
5 Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK 
6 University Department of Geriatric Medicine FELIX PLATTER, Basel, Switzerland 
7 Gérontopôle, Department of Geriatrics, CHU Toulouse, Toulouse, France 
8 Institute for Clinical and Biomedical Research (i.CBR), Faculty of Medicine, University of Coimbra, Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal 
9 Centre for Muscle and Bone Research, Department of Radiology, Charité Universitätsmedizin Berlin, Berlin, Germany 
10 Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland 
11 University of Innsbruck, Innsbruck, Austria 
12 Department of Medicine, Harvard Medical School, Boston, MA, USA 
13 University Clinic for Acute Geriatric Care, City Hospital Waid and Triemli, Zurich, Switzerland 

a michael.gagesch@usz.ch michael.gagesch@usz.ch

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Frailty is a geriatric syndrome associated with multiple negative health outcomes. However, its prevalence varies by population and instrument used. We investigated frailty and pre-frailty prevalence by 5 instruments in community-dwelling older adults enrolled to a randomized-controlled trial in 5 European countries.

Methods

Cross-sectional baseline analysis in 2,144 DO-HEALTH participants recruited from Switzerland, Austria, France, Germany, and Portugal with complete data for frailty. Frailty status was assessed by the Physical Frailty Phenotype [PFP], SOF-Frailty Index [SOF-FI], FRAIL-Scale, SHARE-Frailty Instrument [SHARE-FI], and a modified SHARE-FI, and compared by country, age, and gender. Logistic regression was used to determine relevant factors associated with frailty and pre-frailty.

Results

Mean age was 74.9 (±4.4) years, 61.6% were women. Based on the PFP, overall frailty and pre-frailty prevalence was 3.0% and 43.0%. By country, frailty prevalence was highest in Portugal (13.7%) and lowest in Austria (0%), and pre-frailty prevalence was highest in Portugal (57.3%) and lowest in Germany (37.1%). By instrument and overall, frailty and pre-frailty prevalence was highest based on SHARE-FI (7.0% / 43.7%) and lowest based on SOF-FI (1.0% / 25.9%). Frailty associated factors were residing in Coimbra (Portugal) [OR 12.0, CI 5.30–27.21], age above 75 years [OR 2.0, CI 1.17–3.45], and female gender [OR 2.8, CI 1.48–5.44]. The same three factors predicted pre-frailty.

Conclusions

Among relatively healthy adults age 70 and older enroled to DO-HEALTH, prevalence of frailty and pre-frailty differed significantly by instrument, country, gender, and age. Among instruments, the highest prevalence of frailty and pre-frailty was documented by the SHARE-FI and the lowest by the SOF-FI.

Le texte complet de cet article est disponible en PDF.

Key words : Frailty, community-dwelling, prevalence, clinical trials, epidemiology


Plan


 Prof. Felsenberg is deceased
Electronic Supplementary Material
Supplementary material is available for this article at jfa.2021.18 and is accessible for authorized users.
Copyright comment
corrected publication in 2021
How to cite this article: M. Gagesch, P.O. Chocano-Bedoya, L.A. Abderhalden, et al. Prevalence of Physical Frailty: Results from the DO-HEALTH Study. J Frailty Aging 2022;11(1)18-25; jfa.2021.18
Incomplete funding information during original upload.


© 2021  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 11 - N° 1

P. 18-25 - janvier 2022 Retour au numéro
Article précédent Article précédent
  • Long-Term Aspirin Use and Self-Reported Walking Speed in Older Men: The Physicians’ Health Study
  • Ariela R. Orkaby, A.B. Dufour, L. Yang, H.D. Sesso, J.M. Gaziano, L. Djousse, J.A. Driver, T.G. Travison
| Article suivant Article suivant
  • Association of Dietary Intake with the Transitions of Frailty among Japanese Community-Dwelling Older Adults
  • Rei Otsuka, S. Zhang, C. Tange, Y. Nishita, M. Tomida, K. Kinoshita, Y. Kato, F. Ando, H. Shimokata, H. Arai

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.